These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34057744)

  • 21. Immunoglobulin G in IgE-mediated allergy and allergen-specific immunotherapy.
    Hofmaier S; Comberiati P; Matricardi PM
    Eur Ann Allergy Clin Immunol; 2014 Jan; 46(1):6-11. PubMed ID: 24702866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Molecular Allergen Recognition Profile in China as Basis for Allergen-Specific Immunotherapy.
    D'souza N; Weber M; Sarzsinszky E; Vrtala S; Curin M; Schaar M; Garib V; Focke-Tejkl M; Li Y; Jones R; Chen H; Valenta R; Sun B
    Front Immunol; 2021; 12():719573. PubMed ID: 34512644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allergens. Heterogeneity of molecular sensitization profiles in grass pollen allergy--implications for immunotherapy?
    Darsow U; Brockow K; Pfab F; Jakob T; Petersson CJ; Borres MP; Ring J; Behrendt H; Huss-Marp J
    Clin Exp Allergy; 2014; 44(5):778-86. PubMed ID: 24598010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors influencing the quality of Myrmecia pilosula (Jack Jumper) ant venom for use in in vitro and in vivo diagnoses of allergen sensitization and in allergen immunotherapy.
    Wanandy T; Dwyer HE; McLean L; Davies NW; Nichols D; Gueven N; Brown SGA; Wiese MD
    Clin Exp Allergy; 2017 Nov; 47(11):1478-1490. PubMed ID: 28756642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Interests of recombinant allergens in the practice of allergy].
    Karoui O; Leimgruber A; Spertini F
    Rev Med Suisse; 2013 Jan; 9(368):22-7. PubMed ID: 23367699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Component-resolved evaluation of the content of major allergens in therapeutic extracts for specific immunotherapy of honeybee venom allergy.
    Blank S; Etzold S; Darsow U; Schiener M; Eberlein B; Russkamp D; Wolf S; Graessel A; Biedermann T; Ollert M; Schmidt-Weber CB
    Hum Vaccin Immunother; 2017 Oct; 13(10):2482-2489. PubMed ID: 28494206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Component-resolved diagnosis of house-dust mite allergy with purified natural and recombinant mite allergens.
    Pittner G; Vrtala S; Thomas WR; Weghofer M; Kundi M; Horak F; Kraft D; Valenta R
    Clin Exp Allergy; 2004 Apr; 34(4):597-603. PubMed ID: 15080813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular profiling of allergen-specific antibody responses may enhance success of specific immunotherapy.
    Rodríguez-Domínguez A; Berings M; Rohrbach A; Huang HJ; Curin M; Gevaert P; Matricardi PM; Valenta R; Vrtala S
    J Allergy Clin Immunol; 2020 Nov; 146(5):1097-1108. PubMed ID: 32298697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conference Scene: novelties in immunotherapy.
    Mitsias DI; Kalogiros LA; Papadopoulos NG
    Immunotherapy; 2013 Oct; 5(10):1033-7. PubMed ID: 24088073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allergen component analysis as a tool in the diagnosis and management of occupational allergy.
    Raulf M
    Mol Immunol; 2018 Aug; 100():21-27. PubMed ID: 29650229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Honeybee Venom Major Allergen Api m 10 (Icarapin) and Its Role in Diagnostics and Treatment of Hymenoptera Venom Allergy.
    Jakob T; Rauber MM; Perez-Riverol A; Spillner E; Blank S
    Curr Allergy Asthma Rep; 2020 Jun; 20(9):48. PubMed ID: 32548726
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A molecular diagnostic algorithm to guide pollen immunotherapy in southern Europe: towards component-resolved management of allergic diseases.
    Douladiris N; Savvatianos S; Roumpedaki I; Skevaki C; Mitsias D; Papadopoulos NG
    Int Arch Allergy Immunol; 2013; 162(2):163-72. PubMed ID: 23921568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Contribution of molecular biology to allergology practice].
    Pauli G; Metz-Favre C
    Rev Prat; 2008 Jan; 58(2):129-35. PubMed ID: 18361272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Past, present, and future of allergen immunotherapy vaccines.
    Dorofeeva Y; Shilovskiy I; Tulaeva I; Focke-Tejkl M; Flicker S; Kudlay D; Khaitov M; Karsonova A; Riabova K; Karaulov A; Khanferyan R; Pickl WF; Wekerle T; Valenta R
    Allergy; 2021 Jan; 76(1):131-149. PubMed ID: 32249442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of polysensitized patient: from molecular diagnostics to biomolecular immunotherapy.
    Ciprandi G; Incorvaia C; Frati F;
    Expert Rev Clin Immunol; 2015; 11(9):973-6. PubMed ID: 26144241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombinant allergy vaccines based on allergen-derived B cell epitopes.
    Valenta R; Campana R; Niederberger V
    Immunol Lett; 2017 Sep; 189():19-26. PubMed ID: 28472641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Guidelines for the use of allergen immunotherapy. Canadian Society of Allergy and Clinical Immunology.
    CMAJ; 1995 May; 152(9):1413-9. PubMed ID: 7728690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pretreatment IgE sensitization patterns determine the molecular profile of the IgG4 response during updosing of subcutaneous immunotherapy with timothy grass pollen extract.
    Schmid JM; Würtzen PA; Dahl R; Hoffmann HJ
    J Allergy Clin Immunol; 2016 Feb; 137(2):562-70. PubMed ID: 26141262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allergen immunotherapy.
    Huggins JL; Looney RJ
    Am Fam Physician; 2004 Aug; 70(4):689-96. PubMed ID: 15338781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant allergens for allergen-specific immunotherapy: 10 years anniversary of immunotherapy with recombinant allergens.
    Valenta R; Linhart B; Swoboda I; Niederberger V
    Allergy; 2011 Jun; 66(6):775-83. PubMed ID: 21352238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.